scispace - formally typeset
M

Michael D. Radmacher

Researcher at Ohio State University

Publications -  77
Citations -  13454

Michael D. Radmacher is an academic researcher from Ohio State University. The author has contributed to research in topics: Leukemia & BAALC. The author has an hindex of 40, co-authored 77 publications receiving 12921 citations. Previous affiliations of Michael D. Radmacher include Duke University & Kenyon College.

Papers
More filters
Journal ArticleDOI

High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia.

TL;DR: A role of IGFBP2 and IGF signaling in chemoresistance of AML is suggested and patients with high IGF BP2 expression might benefit from molecular therapies targeting the IGF pathway.
Journal ArticleDOI

MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias.

TL;DR: Results of current studies analysing changes of microRNA expression in acute myeloid leukaemia and chronic lymphocytic leukaemias are reviewed, and their potential biologic, diagnostic and prognostic relevance are discussed.
Journal ArticleDOI

Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α

TL;DR: The transcriptional response of T cells, natural killer cells, and monocytes to IFN-α is described and microarray analysis of patient PBMCs after in vitro stimulation with IFn-α may be a useful predictor of the in vivo response of immune cells to IFM-α immunotherapy.